Cargando…

Development of humoral and cellular immunological memory against SARS-CoV-2 despite B cell depleting treatment in multiple sclerosis

B cell depleting therapies (BCDTs) are widely used as immunomodulating agents for autoimmune diseases such as multiple sclerosis. Their possible impact on development of immunity to severe acute respiratory syndrome virus-2 (SARS-CoV-2) has raised concerns with the coronavirus disease 2019 (COVID-19...

Descripción completa

Detalles Bibliográficos
Autores principales:	Asplund Högelin, Klara, Ruffin, Nicolas, Pin, Elisa, Månberg, Anna, Hober, Sophia, Gafvelin, Guro, Grönlund, Hans, Nilsson, Peter, Khademi, Mohsen, Olsson, Tomas, Piehl, Fredrik, Al Nimer, Faiez
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410640/ https://www.ncbi.nlm.nih.gov/pubmed/34490414 http://dx.doi.org/10.1016/j.isci.2021.103078

Ejemplares similares

B‐cell repopulation dynamics and drug pharmacokinetics impact SARS‐CoV‐2 vaccine efficacy in anti‐CD20‐treated multiple sclerosis patients
por: Asplund Högelin, Klara, et al.
Publicado: (2022)

Identification of four novel T cell autoantigens and personal autoreactive profiles in multiple sclerosis
por: Bronge, Mattias, et al.
Publicado: (2022)

Diagnostic accuracy of intrathecal kappa free light chains compared with OCBs in MS
por: Duell, Frida, et al.
Publicado: (2020)

Complement Component C3 and Butyrylcholinesterase Activity Are Associated with Neurodegeneration and Clinical Disability in Multiple Sclerosis
por: Aeinehband, Shahin, et al.
Publicado: (2015)

Sensitive detection of antigen-specific T-cells using bead-bound antigen for in vitro re-stimulation
por: Bronge, Mattias, et al.
Publicado: (2019)

Sustained Low Relapse Rate With Highly Variable B-Cell Repopulation Dynamics With Extended Rituximab Dosing Intervals in Multiple Sclerosis
por: Starvaggi Cucuzza, Chiara, et al.
Publicado: (2022)

Susceptibility to Oxidative Stress Is Determined by Genetic Background in Neuronal Cell Cultures
por: Günther, Mattias, et al.
Publicado: (2018)

Intense Inflammation and Nerve Damage in Early Multiple Sclerosis Subsides at Older Age: A Reflection by Cerebrospinal Fluid Biomarkers
por: Khademi, Mohsen, et al.
Publicado: (2013)

Fluid proteomics of CSF and serum reveal important neuroinflammatory proteins in blood–brain barrier disruption and outcome prediction following severe traumatic brain injury: a prospective, observational study
por: Lindblad, Caroline, et al.
Publicado: (2021)

Measurement of Horse Allergens Equ c 1 and Equ c 2: A Comparison among Breeds
por: Victor, Susanne, et al.
Publicado: (2022)

Cross-reactive EBNA1 immunity targets alpha-crystallin B and is associated with multiple sclerosis
por: Thomas, Olivia G., et al.
Publicado: (2023)

A comparative study of tolerability and effects on immunoglobulin levels and CD19 cell counts with ocrelizumab vs low dose of rituximab in multiple sclerosis
por: Evertsson, Björn, et al.
Publicado: (2020)

Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelination
por: Al Nimer, Faiez, et al.
Publicado: (2016)

Copy number variations across the blood–brain barrier in multiple sclerosis
por: Bedri, Sahl Khalid, et al.
Publicado: (2022)

Small noncoding RNA profiling across cellular and biofluid compartments and their implications for multiple sclerosis immunopathology
por: Zheleznyakova, Galina Yurevna, et al.
Publicado: (2021)

Memory B Cells Activate Brain-Homing, Autoreactive CD4(+) T Cells in Multiple Sclerosis
por: Jelcic, Ivan, et al.
Publicado: (2018)

Comparative Assessment of the Prognostic Value of Biomarkers in Traumatic Brain Injury Reveals an Independent Role for Serum Levels of Neurofilament Light
por: Al Nimer, Faiez, et al.
Publicado: (2015)

Assessing the Preanalytical Variability of Plasma and Cerebrospinal Fluid Processing and Its Effects on Inflammation-Related Protein Biomarkers
por: Huang, Jesse, et al.
Publicado: (2021)

Characterization of More Selective Central Nervous System Nrf2-Activating Novel Vinyl Sulfoximine Compounds Compared to Dimethyl Fumarate
por: Carlström, Karl E., et al.
Publicado: (2020)

GM-CSF and CXCR4 Define a T Helper Cell Signature in Multiple Sclerosis
por: Galli, Edoardo, et al.
Publicado: (2019)

Variability in C-type lectin receptors regulates neuropathic pain-like behavior after peripheral nerve injury
por: Dominguez, Cecilia A, et al.
Publicado: (2014)

A Serum Protein Biomarker Panel Improves Outcome Prediction in Human Traumatic Brain Injury
por: Thelin, Eric, et al.
Publicado: (2019)

Circulating miR-150 in CSF is a novel candidate biomarker for multiple sclerosis
por: Bergman, Petra, et al.
Publicado: (2016)

Genetic variability in the rat Aplec C-type lectin gene cluster regulates lymphocyte trafficking and motor neuron survival after traumatic nerve root injury
por: Lindblom, Rickard PF, et al.
Publicado: (2013)

Dynamics of cerebrospinal fluid levels of matrix metalloproteinases in human traumatic brain injury
por: Minta, Karolina, et al.
Publicado: (2020)

Antibodies Biotinylated Using a Synthetic Z-domain from Protein A Provide Stringent In Situ Protein Detection
por: Andersson, Sandra, et al.
Publicado: (2013)

Plasma protein profiling reveals candidate biomarkers for multiple sclerosis treatment
por: Bedri, Sahl Khalid, et al.
Publicado: (2019)

Long‐term SARS‐CoV‐2‐specific and cross‐reactive cellular immune responses correlate with humoral responses, disease severity, and symptomatology
por: Laurén, Ida, et al.
Publicado: (2022)

Systemic Inflammation in Progressive Multiple Sclerosis Involves Follicular T-Helper, Th17- and Activated B-Cells and Correlates with Progression
por: Christensen, Jeppe Romme, et al.
Publicado: (2013)

Correction: Systemic Inflammation in Progressive Multiple Sclerosis Involves Follicular T-Helper, Th17- and Activated B-Cells and Correlates with Progression
por: Romme Christensen, Jeppe, et al.
Publicado: (2013)

Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys
por: Alkharaan, Hassan, et al.
Publicado: (2021)

Correction to: Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys
por: Alkharaan, Hassan, et al.
Publicado: (2022)

Complement receptor 2 is up regulated in the spinal cord following nerve root injury and modulates the spinal cord response
por: Lindblom, Rickard P. F., et al.
Publicado: (2015)

SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection
por: Havervall, Sebastian, et al.
Publicado: (2022)

Differences in risk for SARS-CoV-2 infection among healthcare workers
por: Elfström, K. Miriam, et al.
Publicado: (2021)

Recombinant multimeric dog allergen prevents airway hyperresponsiveness in a model of asthma marked by vigorous T(H)2 and T(H)17 cell responses
por: Stark, Julian M., et al.
Publicado: (2022)

Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID‐19
por: Havervall, Sebastian, et al.
Publicado: (2021)

Proceedings: Immunological depletion contributing to familial Hodgkin's disease.
por: Fenelly, J. J., et al.
Publicado: (1974)

The Expression of VEGF-A Is Down Regulated in Peripheral Blood Mononuclear Cells of Patients with Secondary Progressive Multiple Sclerosis
por: Iacobaeus, Ellen, et al.
Publicado: (2011)

A cell-free high throughput assay for assessment of SARS-CoV-2 neutralizing antibodies
por: Mravinacova, Sara, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fm4aitddc0uch24bs7321naavf